| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |